Literature DB >> 20959716

[A comparison of fasting glucose and HbA1c for the diagnosis of diabetes mellitus among Korean adults].

Woo Jun Yun1, Min Ho Shin, Sun Seong Kweon, Kyeong Soo Park, Young Hoon Lee, Hae Sung Nam, Seul Ki Jeong, Yong Woon Yun, Jin Su Choi.   

Abstract

OBJECTIVES: The American Diabetes Association (ADA) has recently recommended the HbA1c assay as one of four options for making the diagnosis of diabetes mellitus, with a cut-point of ≥ 6.5%. We compared the HbA1c assay and the fasting plasma glucose level for making the diagnosis of diabetes among Korean adults.
METHODS: We analyzed 8710 adults (age 45-74 years), who were not diagnosed as having diabetes mellitus, from the Namwon study population. A fasting plasma glucose level of ≥ 126 mg/dL and an A1c of ≥ 6.5% were used for the diagnosis of diabetes. The kappa index of agreement was calculated to measure the agreement between the diagnosis based on the fasting plasma glucose level and the HbA1c.
RESULTS: The kappa index of agreement between the fasting plasma glucose level and HbA1c was 0.50.
CONCLUSIONS: The agreement between the fasting plasma glucose and HbA1c for the diagnosis of diabetes was moderate for Korean adults.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20959716     DOI: 10.3961/jpmph.2010.43.5.451

Source DB:  PubMed          Journal:  J Prev Med Public Health        ISSN: 1975-8375


  3 in total

1.  Epidemiological ramifications of diagnosing diabetes with HbA1c levels.

Authors:  Mayer B Davidson; Deyu Pan
Journal:  J Diabetes Complications       Date:  2014-04-02       Impact factor: 2.852

2.  Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos.

Authors:  Mayer B Davidson; Petra Duran; Martin L Lee
Journal:  Ethn Dis       Date:  2014       Impact factor: 1.847

3.  An emerging diabetes mellitus diagnosis modality: HbA(1c).

Authors:  Hyun-Ae Seo; In-Kyu Lee
Journal:  Korean J Intern Med       Date:  2012-02-28       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.